Next-generation sequencing data analysis | software and service
AptaIT is a bioinformatics company dedicated to help researchers worldwide to analyze data from next-generation sequencing (NGS) by user-friendly bioinformatic solutions to enhance their biomedical development programs. AptaIT has developed intelligent software solutions with an emphasis to discovery platforms of novel biologics by in vitro selection strategies or by analyzing the natural immune response (TCR/BCR).
We help our customers to exploit the statistical power of next-generation sequencing data analysis, which provides accelerated and advanced sequence information of potential ligands.
AptaIT - Reduce to the Best
Next-generation sequencing currently transforms many drug discovery or diagnostic research platforms.
AptaIT is anticipating this development and provides novel bioinformatic solutions for next-generation sequencing data analysis of drug discovery procedures based on combinatorial in vitro selection strategies or investigating the immune system. Millions of sequencing data are available for one experiment but the search for the optimal biomolecules is a challenging process. We help to solve this bottleneck by streamlining the identification of the best biologics.
AptaIT provides tailored solutions for every need: We offer extensive analysis services for sequencing data of aptamers, phage or other display procedures, and the analysis of BCR & TCR repertoires in immunoprofiling experiments. Additionally, we provide flexible arrangements for licensing our user-friendly software AptaAnalyzer™ software enabling our customers to perform their own next-generation sequencing analysis.